Stonepine Capital Management as of Sept. 30, 2025
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 58 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Verastem Com New (VSTM) | 19.2 | $24M | 2.7M | 8.83 | |
| Adma Biologics (ADMA) | 8.8 | $11M | 739k | 14.66 | |
| Evolus (EOLS) | 7.7 | $9.4M | 1.5M | 6.14 | |
| Zevra Therapeutics Com New (ZVRA) | 6.3 | $7.7M | 810k | 9.51 | |
| Nektar Therapeutics Com New (NKTR) | 3.9 | $4.8M | 85k | 56.90 | |
| Day One Biopharmaceuticals I (DAWN) | 3.7 | $4.6M | 647k | 7.05 | |
| Xoma Royalty Corporation Com New (XOMA) | 3.6 | $4.4M | 116k | 38.54 | |
| ACADIA Pharmaceuticals (ACAD) | 3.0 | $3.7M | 175k | 21.34 | |
| Enanta Pharmaceuticals (ENTA) | 3.0 | $3.7M | 305k | 11.97 | |
| X4 Pharmaceuticals Com New (XFOR) | 2.9 | $3.6M | 1.1M | 3.42 | |
| Omniab (OABI) | 2.8 | $3.4M | 2.1M | 1.60 | |
| Surrozen Com New (SRZN) | 2.6 | $3.2M | 250k | 12.88 | |
| Tela Bio (TELA) | 2.6 | $3.2M | 2.2M | 1.49 | |
| Indivior Ord (INDV) | 2.0 | $2.4M | 100k | 24.11 | |
| Abeona Therapeutics Com New (ABEO) | 1.9 | $2.4M | 451k | 5.28 | |
| Geron Corporation (GERN) | 1.8 | $2.2M | 1.6M | 1.37 | |
| Pmv Pharmaceuticals (PMVP) | 1.6 | $1.9M | 1.4M | 1.40 | |
| Edesa Biotech Com New (EDSA) | 1.4 | $1.7M | 688k | 2.47 | |
| Aytu Biopharma (AYTU) | 1.4 | $1.7M | 892k | 1.88 | |
| Soleno Therapeutics (SLNO) | 1.3 | $1.6M | 24k | 67.60 | |
| Kezar Life Sciences Com New (KZR) | 1.2 | $1.5M | 383k | 3.90 | |
| Alumis (ALMS) | 1.0 | $1.2M | 300k | 3.99 | |
| Inhibikase Therapeutics Com New (IKT) | 1.0 | $1.2M | 735k | 1.62 | |
| Bioage Labs (BIOA) | 0.9 | $1.1M | 189k | 5.88 | |
| Ardelyx (ARDX) | 0.9 | $1.1M | 200k | 5.51 | |
| Pulmonx Corp (LUNG) | 0.9 | $1.1M | 670k | 1.62 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.9 | $1.1M | 108k | 9.93 | |
| Heron Therapeutics (HRTX) | 0.9 | $1.1M | 850k | 1.26 | |
| Vanda Pharmaceuticals (VNDA) | 0.8 | $973k | 195k | 4.99 | |
| Vir Biotechnology (VIR) | 0.7 | $914k | 160k | 5.71 | |
| Mannkind Corp Com New (MNKD) | 0.7 | $846k | 158k | 5.37 | |
| Maxcyte (MXCT) | 0.6 | $725k | 459k | 1.58 | |
| An2 Therapeutics (ANTX) | 0.6 | $716k | 564k | 1.27 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.6 | $685k | 454k | 1.51 | |
| AngioDynamics (ANGO) | 0.5 | $670k | 60k | 11.17 | |
| Acasti Pharma (GRCE) | 0.5 | $628k | 211k | 2.98 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $602k | 20k | 30.08 | |
| Syndax Pharmaceuticals (SNDX) | 0.5 | $572k | 37k | 15.38 | |
| Aquestive Therapeutics (AQST) | 0.5 | $562k | 101k | 5.59 | |
| Gossamer Bio (GOSS) | 0.4 | $539k | 205k | 2.63 | |
| Boundless Bio (BOLD) | 0.4 | $509k | 414k | 1.23 | |
| Health Catalyst (HCAT) | 0.4 | $443k | 156k | 2.85 | |
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $434k | 11k | 40.99 | |
| Pliant Therapeutics (PLRX) | 0.3 | $428k | 289k | 1.48 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $399k | 125k | 3.19 | |
| Kiora Pharmaceuticals (KPRX) | 0.3 | $391k | 141k | 2.78 | |
| Rezolute Com New (RZLT) | 0.3 | $376k | 40k | 9.40 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $367k | 193k | 1.90 | |
| In8bio Com New (INAB) | 0.3 | $346k | 159k | 2.17 | |
| Helius Med Technologies Com Cl A New (HSDT) | 0.2 | $298k | 20k | 14.89 | |
| Codexis (CDXS) | 0.2 | $215k | 88k | 2.44 | |
| Savara (SVRA) | 0.2 | $214k | 60k | 3.57 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.2 | $212k | 2.5k | 84.90 | |
| Processa Pharmaceuticals Com Shs (PCSA) | 0.2 | $198k | 1.0M | 0.19 | |
| Larimar Therapeutics (LRMR) | 0.1 | $81k | 25k | 3.23 | |
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.1 | $79k | 30k | 2.63 | |
| Aadi Bioscience (WHWK) | 0.1 | $67k | 35k | 1.90 | |
| Jasper Therapeutics Com New (JSPR) | 0.0 | $48k | 20k | 2.38 |
